Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure

Seiko Endo, Aiko Fukahori, Shinya Tokuhiro, Akira Shinagawa, Joseph Walker, Kazutaka Yoshihara, Hitoshi Ishizuka, Ichiro Ieiri, Yuichi Sugiyama

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

It has been reported that organic anion-transporting polypeptide (OATP) 1B1, OATP1B3 and multidrug resistance-associated protein 2 are involved in the hepatobiliary transport of olmesartan. We investigated the association of SLCO1B1, SLCO1B3 and ABCC2 polymorphisms with the pharmacokinetics of olmesartan. We sequenced all exons, exon-intron junctions and the 5′ and 3′ flanking regions of the three genes in 115 individuals from African-American, Hispanic and Caucasian populations who had participated in our clinical studies. A total of 348 single-nucleotide polymorphisms (SNPs) were identified with a minor allele frequency of 0.01 in at least one population; 132 SNPs were detected in SLCO1B1, 130 in SLCO1B3 and 86 in ABCC2. We characterized the linkage disequilibrium (LD) and haplotypes shared across the populations and then evaluated the association between the haplotypes and the pharmacokinetics of olmesartan. Seven inter-ethnic LD blocks were observed in SLCO1B1, while three in SLCO1B3 and four in ABCC2. Although extensive variability in the sequences of SLCO1B1, SLCO1B3 and ABCC2 existed across the three populations, there was no remarkable difference in any pharmacokinetic parameters of olmesartan between subjects with and without any major haplotypes in the three transporter genes we tested.

Original languageEnglish
Pages (from-to)531-544
Number of pages14
JournalJournal of Human Genetics
Volume57
Issue number8
DOIs
Publication statusPublished - Aug 1 2012

Fingerprint

Genetic Polymorphisms
Hispanic Americans
African Americans
Haplotypes
Pharmacokinetics
Linkage Disequilibrium
Pharmaceutical Preparations
Population
Single Nucleotide Polymorphism
Exons
3' Flanking Region
5' Flanking Region
Gene Frequency
Introns
Genes
Anions
Peptides
olmesartan

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure. / Endo, Seiko; Fukahori, Aiko; Tokuhiro, Shinya; Shinagawa, Akira; Walker, Joseph; Yoshihara, Kazutaka; Ishizuka, Hitoshi; Ieiri, Ichiro; Sugiyama, Yuichi.

In: Journal of Human Genetics, Vol. 57, No. 8, 01.08.2012, p. 531-544.

Research output: Contribution to journalArticle

Endo, Seiko ; Fukahori, Aiko ; Tokuhiro, Shinya ; Shinagawa, Akira ; Walker, Joseph ; Yoshihara, Kazutaka ; Ishizuka, Hitoshi ; Ieiri, Ichiro ; Sugiyama, Yuichi. / Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure. In: Journal of Human Genetics. 2012 ; Vol. 57, No. 8. pp. 531-544.
@article{f8edf6645f88444b9f398fc9e2f6a2a9,
title = "Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure",
abstract = "It has been reported that organic anion-transporting polypeptide (OATP) 1B1, OATP1B3 and multidrug resistance-associated protein 2 are involved in the hepatobiliary transport of olmesartan. We investigated the association of SLCO1B1, SLCO1B3 and ABCC2 polymorphisms with the pharmacokinetics of olmesartan. We sequenced all exons, exon-intron junctions and the 5′ and 3′ flanking regions of the three genes in 115 individuals from African-American, Hispanic and Caucasian populations who had participated in our clinical studies. A total of 348 single-nucleotide polymorphisms (SNPs) were identified with a minor allele frequency of 0.01 in at least one population; 132 SNPs were detected in SLCO1B1, 130 in SLCO1B3 and 86 in ABCC2. We characterized the linkage disequilibrium (LD) and haplotypes shared across the populations and then evaluated the association between the haplotypes and the pharmacokinetics of olmesartan. Seven inter-ethnic LD blocks were observed in SLCO1B1, while three in SLCO1B3 and four in ABCC2. Although extensive variability in the sequences of SLCO1B1, SLCO1B3 and ABCC2 existed across the three populations, there was no remarkable difference in any pharmacokinetic parameters of olmesartan between subjects with and without any major haplotypes in the three transporter genes we tested.",
author = "Seiko Endo and Aiko Fukahori and Shinya Tokuhiro and Akira Shinagawa and Joseph Walker and Kazutaka Yoshihara and Hitoshi Ishizuka and Ichiro Ieiri and Yuichi Sugiyama",
year = "2012",
month = "8",
day = "1",
doi = "10.1038/jhg.2012.63",
language = "English",
volume = "57",
pages = "531--544",
journal = "Journal of Human Genetics",
issn = "1434-5161",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure

AU - Endo, Seiko

AU - Fukahori, Aiko

AU - Tokuhiro, Shinya

AU - Shinagawa, Akira

AU - Walker, Joseph

AU - Yoshihara, Kazutaka

AU - Ishizuka, Hitoshi

AU - Ieiri, Ichiro

AU - Sugiyama, Yuichi

PY - 2012/8/1

Y1 - 2012/8/1

N2 - It has been reported that organic anion-transporting polypeptide (OATP) 1B1, OATP1B3 and multidrug resistance-associated protein 2 are involved in the hepatobiliary transport of olmesartan. We investigated the association of SLCO1B1, SLCO1B3 and ABCC2 polymorphisms with the pharmacokinetics of olmesartan. We sequenced all exons, exon-intron junctions and the 5′ and 3′ flanking regions of the three genes in 115 individuals from African-American, Hispanic and Caucasian populations who had participated in our clinical studies. A total of 348 single-nucleotide polymorphisms (SNPs) were identified with a minor allele frequency of 0.01 in at least one population; 132 SNPs were detected in SLCO1B1, 130 in SLCO1B3 and 86 in ABCC2. We characterized the linkage disequilibrium (LD) and haplotypes shared across the populations and then evaluated the association between the haplotypes and the pharmacokinetics of olmesartan. Seven inter-ethnic LD blocks were observed in SLCO1B1, while three in SLCO1B3 and four in ABCC2. Although extensive variability in the sequences of SLCO1B1, SLCO1B3 and ABCC2 existed across the three populations, there was no remarkable difference in any pharmacokinetic parameters of olmesartan between subjects with and without any major haplotypes in the three transporter genes we tested.

AB - It has been reported that organic anion-transporting polypeptide (OATP) 1B1, OATP1B3 and multidrug resistance-associated protein 2 are involved in the hepatobiliary transport of olmesartan. We investigated the association of SLCO1B1, SLCO1B3 and ABCC2 polymorphisms with the pharmacokinetics of olmesartan. We sequenced all exons, exon-intron junctions and the 5′ and 3′ flanking regions of the three genes in 115 individuals from African-American, Hispanic and Caucasian populations who had participated in our clinical studies. A total of 348 single-nucleotide polymorphisms (SNPs) were identified with a minor allele frequency of 0.01 in at least one population; 132 SNPs were detected in SLCO1B1, 130 in SLCO1B3 and 86 in ABCC2. We characterized the linkage disequilibrium (LD) and haplotypes shared across the populations and then evaluated the association between the haplotypes and the pharmacokinetics of olmesartan. Seven inter-ethnic LD blocks were observed in SLCO1B1, while three in SLCO1B3 and four in ABCC2. Although extensive variability in the sequences of SLCO1B1, SLCO1B3 and ABCC2 existed across the three populations, there was no remarkable difference in any pharmacokinetic parameters of olmesartan between subjects with and without any major haplotypes in the three transporter genes we tested.

UR - http://www.scopus.com/inward/record.url?scp=84865675192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865675192&partnerID=8YFLogxK

U2 - 10.1038/jhg.2012.63

DO - 10.1038/jhg.2012.63

M3 - Article

VL - 57

SP - 531

EP - 544

JO - Journal of Human Genetics

JF - Journal of Human Genetics

SN - 1434-5161

IS - 8

ER -